Ontology highlight
ABSTRACT: Background
Large-scale genomic alterations, especially CD274/PD-L1 gene amplification, have great impact on anti-PD-1 efficacy on cancers such as Hodgkin's lymphoma. However, the prevalence of PD-L1 genetic alterations in colorectal cancer (CRC) and its correlation with the tumor immune microenvironment and clinical implications remain unknown.Materials and methods
PD-L1 genetic alterations were evaluated in 324 patients with newly diagnosed CRC including 160 mismatch repair-deficient (dMMR) patients and 164 mismatch repair-proficient (pMMR) patients using fluorescence in situ hybridization (FISH) method. The correlation between PD-L1 and the expression of the common immune markers was analyzed.Results
Totally 33 (10.2%) patients were identified with aberrant PD-L1
SUBMITTER: Yang L
PROVIDER: S-EPMC9996909 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature